These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28273180)

  • 1. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    De Lombaerde S; Neyt S; Kersemans K; Verhoeven J; Devisscher L; Van Vlierberghe H; Vanhove C; De Vos F
    PLoS One; 2017; 12(3):e0173529. PubMed ID: 28273180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Hepatobiliary Transport with
    De Lombaerde S; Kersemans K; Neyt S; Verhoeven J; Vanhove C; De Vos F
    Contrast Media Mol Imaging; 2018; 2018():6345412. PubMed ID: 29853807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[
    De Lombaerde S; Devisscher L; Verhoeven J; Neyt S; Van Vlierberghe H; Vanhove C; De Vos F
    Nucl Med Biol; 2019; 68-69():40-48. PubMed ID: 30595544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
    Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
    Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters.
    Testa A; Dall'Angelo S; Mingarelli M; Augello A; Schweiger L; Welch A; Elmore CS; Sharma P; Zanda M
    Bioorg Med Chem; 2017 Feb; 25(3):963-976. PubMed ID: 28011201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary transport kinetics of the conjugated bile acid tracer
    Ørntoft NW; Munk OL; Frisch K; Ott P; Keiding S; Sørensen M
    J Hepatol; 2017 Aug; 67(2):321-327. PubMed ID: 28249726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.
    Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis.
    Lapham K; Novak J; Marroquin LD; Swiss R; Qin S; Strock CJ; Scialis R; Aleo MD; Schroeter T; Eng H; Rodrigues AD; Kalgutkar AS
    Chem Res Toxicol; 2016 Oct; 29(10):1778-1788. PubMed ID: 27676153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.
    De Bruyn T; Sempels W; Snoeys J; Holmstock N; Chatterjee S; Stieger B; Augustijns P; Hofkens J; Mizuno H; Annaert P
    J Pharm Sci; 2014 Jun; 103(6):1872-81. PubMed ID: 24652646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia.
    Hartmann G; Cheung AK; Piquette-Miller M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):273-81. PubMed ID: 12235261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation of [
    Testa A; Dall'Angelo S; Mingarelli M; Augello A; Schweiger L; Welch A; Elmore CS; Dawson D; Sharma P; Zanda M
    Contrast Media Mol Imaging; 2018; 2018():3064751. PubMed ID: 30154685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
    Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
    Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.
    Wanek T; Halilbasic E; Visentin M; Mairinger S; Römermann K; Stieger B; Kuntner C; Müller M; Langer O; Trauner M
    J Pharm Sci; 2016 Jan; 105(1):106-12. PubMed ID: 26852845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(4-[
    Frisch K; Stimson DHR; Venkatachalam T; Pierens GK; Keiding S; Reutens D; Bhalla R
    Nucl Med Biol; 2018 Jun; 61():56-62. PubMed ID: 29783201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.